SB
SBI Equity Minimum Variance Fund Direct Growth
Latest NAV
-6.39% 1Y
Sign In to Add to Portfolio
Benchmark: Nifty 50 TRI
Expense ratio
0.55%
AUM
₹208 Cr
Min SIP
₹500
Min lump sum
₹5,000
1Y
-6.39%
3Y (ann.)
+5.69%
5Y (ann.)
+7.17%
Launched
Mar 2019
Where the NAV sits & how risky it is
₹22.91
52-week range
at 20%
₹22.91
Low 31 Mar 2026₹22.26
High 26 Nov 2025₹25.57
Risk level
Very High
Low
Very high
NAV history
27 Mar 2019
Since inception
05 Oct 2026
Returns by period
1W
-3.47%
1M
-6.24%
3M
-6.64%
6M
+1.91%
1Y
-6.39%
3Y
+5.69%
5Y
+7.17%
3Y and 5Y returns are annualised.
Return calculator
You invest
—
Est. gain
—
Est. value
—
Invested Gain
Invested
Projected value
min SIP ₹500
Estimate only. It assumes the selected past return repeats every year; 3Y and 5Y figures are taken as annualised. Actual returns vary and are not guaranteed.
Where your money goes
AS OF 31 MAY 2026
Equity 98.93%
Cash & other 1.07%
Sector split
Country split
Top 5 hold 36.9%
Top 10 hold 54.1%
50 equity holdings
Equity holdings
(top 30)
| # | Holding | Sector | Country | Weight | YTD |
|---|---|---|---|---|---|
| 1 | Nestle
INE239A01024 |
Consumer Defensive Packaged Foods |
India |
8.74%
|
+9.15% |
| 2 | Sun Pharmaceutical
INE044A01036 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
7.78%
|
+4.66% |
| 3 | Hindustan Unilever
INE030A01027 |
Consumer Defensive Household & Personal Products |
India |
7.64%
|
-8.89% |
| 4 | Tata Consumer Products
INE192A01025 |
Consumer Defensive Packaged Foods |
India |
6.56%
|
-6.29% |
| 5 | ITC
INE154A01025 |
Consumer Defensive Tobacco |
India |
6.13%
|
-27.06% |
| 6 | Cipla
INE059A01026 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
5.26%
|
-7.30% |
| 7 | Apollo Hospitals
INE437A01024 |
Healthcare Medical Care Facilities |
India |
3.39%
|
+18.83% |
| 8 | Dr Reddys Laboratories
INE089A01031 |
Healthcare Drug Manufacturers - Specialty & Generic |
India |
3.30%
|
+0.33% |
| 9 | Asian Paints
INE021A01026 |
Basic Materials Specialty Chemicals |
India |
2.74%
|
-3.98% |
| 10 | ICICI Bank
INE090A01021 |
Financial Services Banks - Regional |
India |
2.52%
|
-6.90% |
About this scheme
The investment objective of the scheme is to provide long term capital appreciation by investing in a diversified basket of companies in Nifty 50 Index while aiming for minimizing the portfolio volatility. However, there is no guarantee or assurance that the investment objective of the scheme will be achieved.
Fund manager(s): Sukanya Ghosh
Exit load: Exit load of 0.5% if redeemed within 15 days.
Scheme snapshot
VR Rating
MS Rating
Plan
Growth
Type
DIRECT
Inception
19 Mar 2019
Lump-sum min
₹5,000
SIP
Purchase
Switch
STP
SWP
Similar schemes
RANKED BY 1Y RETURN
Nippon India Taiwan Equity Fund Direct Growth
1▲ 127.9 pts ahead of this fund
Franklin Asian Equity Fund Direct Growth
2▲ 39.8 pts ahead of this fund
Nippon India Japan Equity Fund - Direct Plan - Growth Plan - Bonus Option
3▲ 37.0 pts ahead of this fund
Nippon India Japan Equity Fund Direct Growth
4▲ 37.0 pts ahead of this fund
Bank of India Small Cap Fund Direct Growth
5▲ 35.6 pts ahead of this fund
TRUSTMF Small Cap Fund Direct Growth
6▲ 35.5 pts ahead of this fund